NCT05849116

Brief Summary

Respiratory distress syndrome (RDS) in preterm babies is caused by a deficiency of lung surfactant. The risk of RDS increases with decreasing gestational age, and is almost inevitable in babies born at less than 28 weeks gestation. Without surfactant the lungs become stiff and the alveoli collapse at end-expiration, and untreated RDS is a major cause of morbidity and mortality in preterm infants

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2023

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 24, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 8, 2023

Completed
24 days until next milestone

Study Start

First participant enrolled

June 1, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2024

Completed
Last Updated

May 8, 2023

Status Verified

May 1, 2023

Enrollment Period

1 year

First QC Date

March 24, 2023

Last Update Submit

May 5, 2023

Conditions

Outcome Measures

Primary Outcomes (4)

  • The rate of invasive mechanical ventilation at the first 72 hours of life.

    Regarding the following aspect: The effect of high flow nasal cannula versus CPAP on the clinical outcomes of preterm infants with respiratory distress syndrome regarding the need for invasive mechanical ventilation at the first 72 hours of life.

    first 72 hours of life

  • Time for weaning off from oxygen.

    Regarding the following aspect: The effect of high flow nasal cannula versus CPAP on the clinical outcomes of preterm infants with respiratory distress syndrome regarding the time for weaning off from oxygen.

    Baseline

  • Duration of hospital stay.

    Regarding the following aspect: The effect of high flow nasal cannula versus CPAP on the clinical outcomes of preterm infants with respiratory distress syndrome regarding the duration of hospital stay.

    Baseline

  • Rate of morbidity and mortality.

    Regarding the following aspect: The effect of high flow nasal cannula versus CPAP on the clinical outcomes of preterm infants with respiratory distress syndrome regarding the effect on morbidity and mortality.

    Baseline

Study Arms (2)

High flow nasal cannula

preterms infants who are connected to high flow nasal cannula

Continuous positive airway pressure

preterms who are connected to continuous positive airway pressure

Eligibility Criteria

Age30 Weeks - 37 Weeks
Sexall
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

100 preterm infants between 30 weeks and 37 weeks

You may qualify if:

  • Preterm infants ≥30 weeks
  • Preterm infants with birth weight \>1000 gm
  • Preterm infants diagnosed with respiratory distress syndrome.

You may not qualify if:

  • Full term infants (\>37 weeks)
  • Preterm infants (\<30 weeks \& less than 1000 gm)
  • Neonates with respiratory distress other than respiratory distress syndrome.
  • Neonates with neonatal sepsis.
  • Neonates with congenital anomalies including congenital heart diseases.
  • Neonates who need invasive MV immediately after birth.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Respiratory Distress Syndrome

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesRespiration Disorders

Study Officials

  • Gafar Ibrahim, Prof

    Assiut University

    PRINCIPAL INVESTIGATOR
  • Safwat Moahmed, Assist prof

    Assiut University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 24, 2023

First Posted

May 8, 2023

Study Start

June 1, 2023

Primary Completion

June 1, 2024

Study Completion

August 1, 2024

Last Updated

May 8, 2023

Record last verified: 2023-05